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Abstract:  
Redundancy among sequence identifiers is a recurring problem in bioinformatics. Here, we present a rapid and efficient method of fingerprinting identifiers to 
ascertain whether two or more aliases are identical. A number of tools and approaches have been developed to resolve differing names for the same genes and 
proteins, however, these methods each have their own limitations associated with their various goals. We have taken a different approach to the aliasing problem 
by simplifying the way aliases are stored and curated with the objective of simultaneously achieving speed and flexibility. Our approach (Booly-hashing) is to link 
identifiers with their corresponding hash keys derived from unique fingerprints such as gene or protein sequences. This tool has proven invaluable for designing a 
new data integration platform known as Booly, and has wide applicability to situations in which a dedicated efficient aliasing system is required. Compared with 
other aliasing techniques, Booly-hashing methodology provides 1) reduced run time complexity, 2) increased flexibility (aliasing of other data types, e.g. 
pharmaceutical drugs), 3) no required assumptions regarding gene clusters or hierarchies, and 4) simplicity in data addition, updating, and maintenance. The new 
Booly-hashing aliasing model has been incorporated as a central component of the Booly data integration platform we have recently developed and shoud be 
broadly applicable to other situations in a which an efficient streamlined aliasing systems is required. This aliasing tool and database, which allows users to quickly 
group the same genes and proteins together can be accessed at: http://booly.ucsd.edu/alias. 
 
 
Availability: http://booly.ucsd.edu/alias 
 
 
 
 
Background:  
A common problem confronted by bioinformaticians is the need to resolve 
whether two or more identifiers are identical, i.e., are aliases of each other. A 
number of aliasing services have attempted to resolve the differing naming 
conventions created by both computational and manual labelling methods 
(AliasServer, DAVID, HGNC, SEGUID, MagicMatch, NCBI, ENSEMBL) [1-
7]. These services differ by their technology and solutions with the general 
strategy of 1) using either in-house generated unique identifiers (NCBI, 
DAVID, ENSEMBL), or 2) the generation of unique fingerprints (AliasServer, 
MagicMatch, SEGUID) by way of cryptographic hashing algorithms which 
digest large arbitrary blocks of data (e.g., sequence) and returns a fixed-size bit 
string [8]. As each of these systems is designed with a specific goal in mind, 
none of them are optimized for specifically answering the single root question: 
are two identifiers the same? (Figure 1a)  
 
In the course of designing a comprehensive data warehousing and comparison 
application called Booly [9], we recognized a need for a dedicated aliasing tool 
designed to efficiently and flexibly resolve alias identities. One of the main 
tasks of Booly is to mix and match datasets together using combinations of the 
Boolean operations. A common usage of such a tool is data aggregation 
between multiple sources (e.g. the aggregation of Gene Ontology data to that of 
a home brew spreadsheet table for annotation). When identifiers from both 
datasets are in the same format (e.g., gene symbol), the process of integrating 
the data can be performed trivially. However, the process of integrating the 
data becomes more challenging when converting formats is needed, thus 
becoming an unwieldy aliasing problem. This aliasing problem is compounded 
when comparing multiple datasets with differing identifier formats. 
Furthermore, Booly was created to compare content that extends beyond 
sequence data (e.g., databases of pharmaceutical drugs, human diseases, or 
other web-based content). With these requirements in mind, we designed an 
aliasing system (Booly-hashing) that can quickly resolve heterogeneous 
identifiers from multiple sources while maintaining flexibility to handle aliases 
from multiple entities. 
 
Booly-hashing is an aliasing database resource that utilizes a 160-bit Secure 
Hash Algorithm (SHA) hash key to generate unique fingerprints of sequences 
and their identifiers represented as a 40 character hexadecimal number (Figure 
1a) [10]. Our streamlined approach requires the storage of only the hash key 
and its associated identifier. Current aliasing methods utilizing the hashing 
technology require the source of the identifiers to be known (AliasServer, 
SEGUID)  [1, 5]. This limits the ability to find aliases of identifiers from 
heterogeneous sources. Our simplified technique is more broadly applicable as 
it allows for conversion to known hash keys for any identifier regardless of 
originating source. Another aliasing approach is to convert aliases into known, 
reference identifiers (e.g. RefSeq, Genebank Gene ID) such that one can then 
easily ascertain whether two identifiers are the same (DAVID) [3]. However, 
this approach is insufficient as some reference databases are incomplete and 
lack the overlap required to be inclusive of all known sequences and their BIOINFORMATION  open access 
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identifiers (Table 1 see Supplementary material). In contrast, our aliasing 
approach utilizes the sequence hash key as a singular point of conversion. 
Finally, unlike other sequence-related aliasing technologies, we have developed 
our Booly-hashing infrastructure to accommodate aliases from other sources 
such as pharmaceutical drugs or keyword aliases. As an example, in the case of 
pharmaceutical drugs, the unique fingerprint is the chemical formula that 
remains intact despite multiple branding names. A comparison table of the 
differences in features among our approach and other aliasing tools can be 
found in Figure 1b. In aggregate, our aliasing method allows one to efficiently 
and accurately ascertain whether two or more identifiers are aliases of each 
other. Furthermore, our streamlined approach is flexible and easy to modify 
and update. We have incorporated this aliasing model as part of a core 
component in Booly, our data integration platform designed to aid researchers 
in making new connections leading to novel discoveries in the laboratory. This 
generalized aliasing system should be of similar utility for development of 
other comparative tools that also have the simple requirement of rapidly 
deciding whether two identifiers are the same. Additionally, we have created an 
online tool that simply takes as input a list of identifiers and groups them 
accordingly into similar gene or protein sequence clusters. 
 
 
Figure 1: Booly aliasing resource. (a) Difference between other aliasing 
approaches and the Booly-hashing method. The single question we wish to 
answer efficiently is, whether two identifiers (e.g., FBgn0000055 and ADH) are 
one and the same? Booly-hashing utilizes a 160-bit SHA-1 hash key to 
generate unique fingerprints of sequences and their identifiers represented as a 
40 character hexadecimal number. Identifiers with the same hash-keys are 
considered as aliases of each other. Other approaches require knowledge of the 
source of the original identifier or knowledge of a conversion format requiring 
additional steps that increase complexity and programming (b) Comparison of 
two commonly used aliasing tools in bioinformatics (AliasServer and DAVID 
Gene Conversion Tool) against the Booly-hashing resource.  
 
Summary: 
The process of determining whether two or more identifiers are aliases of each 
other is a common recurring problem in bioinformatics. To this end, we have 
created a streamlined aliasing method that utilizes a fingerprint such as a 
sequence or chemical formula for the purpose of creating unique hash-key 
identifiers. Our approach affords us a number of advantages over existing 
aliasing solutions, including a reduction in run time complexity, increased 
flexibility, flexible alias clusters, and simplicity in addition of new data, 
updating, and maintenance. In addition to performing well for Booly, these 
advantages should allow better integration of data containing heterogeneous 
identifiers leading to new connections and novel discoveries within many fields 
of science. 
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Supplementary material: 
 
Table 1: Redundancy of common reference databases. The DAVID Gene Conversion tool creates clusters of gene groups analogous to Entrez Gene. Gene clusters 
from DAVID are labeled with numerical identifiers that are reused and recycled after each update, thus not optimal for use as a reference identifier of a gene. A 
common approach is to convert aliases into a single source database (REFSEQ, Entrez, etc.) identifier for comparison. The table shows the lack of complete 
redundancy across multiple reference databases. Only 29% (37081/127749) of gene clusters identified by DAVID (v6.7) are found to be present in all five 
reference databases from the three organisms. 
Unique DAVID Id's Mapped  Fruitfly  Mouse  Human  Total 
DAVID-Refseq mRNA  13978  16262  16060  46300 
DAVID-Entrez Gene ID  21227  58530  40959  120716 
DAVID-Ensembl ID  13945  18307  18370  50622 
DAVID-Genbank GI  14253  48480  37281  100014 
DAVID-Gene Symbol  20571  44859  32100  97530 
Total DAVID ID Overlap   11525  13231  12325  37081 
Total Unique DAVID IDs  23569  59881  44299  127749 
 
 